GlaxoSmithKline Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
You can view the
Nine Months Results
for the last 5 years.
Market Cap. (Rs.)
|
47393.03 Cr.
|
P/BV
|
28.33
|
Book Value (Rs.)
|
98.74
|
52 Week High/Low (Rs.)
|
3148/1921
|
FV/ML
|
10/1
|
P/E(X)
|
79.77
|
Bookclosure
|
07/11/2024
|
EPS (Rs.)
|
35.07
|
Div Yield (%)
|
1.14
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 2774.84 | 2523.91 | 2464.27 | 2468.40 | 2385.11 |
Total Income From Operations | 2774.84 | 2523.91 | 2464.27 | 2468.40 | 2385.11 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 384.67 | 340.57 | 333.38 | 463.08 | 325.34 |
Purchase of Traded Goods | 553.71 | 597.34 | 610.64 | 545.34 | 654.31 |
Increase/Decrease in Stocks | 100.54 | 29.49 | -3.94 | -3.59 | -3.60 |
Employees Cost | 426.73 | 451.56 | 446.15 | 470.19 | 465.14 |
Depreciation | 52.07 | 51.58 | 48.59 | 52.84 | 61.43 |
Other Expenses | 465.02 | 453.52 | 443.49 | 406.72 | 419.48 |
Total Expenses | 1982.74 | 1924.06 | 1878.31 | 1934.58 | 1922.10 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 792.10 | 599.85 | 585.96 | 533.82 | 463.01 |
Other Income | 105.25 | 92.76 | 73.00 | 57.02 | 80.98 |
P/L Before Interest, Excpt. Items & Tax | 897.35 | 692.61 | 658.96 | 590.84 | 543.99 |
Interest | 0.73 | 1.03 | 1.16 | 1.72 | 2.90 |
P/L Before Exceptional Items & Tax | 896.62 | 691.58 | 657.80 | 589.12 | 541.09 |
Exceptional Items | 4.69 | -146.01 | -11.37 | -17.92 | -53.60 |
P/L Before Tax | 901.31 | 545.57 | 646.43 | 571.20 | 487.49 |
Tax | 236.60 | 150.09 | 172.22 | 135.77 | 143.67 |
P/L After Tax from Ordinary Activities | 664.71 | 395.48 | 474.21 | 435.43 | 343.82 |
Extra Ordinary Item | 0.00 | 0.00 | 3.05 | 40.24 | 0.00 |
Net Profit/Loss For the Period | 664.71 | 395.48 | 477.26 | 475.67 | 343.82 |
Net P/L After Minority Interest & Share Of Associates | 664.71 | 395.48 | 477.26 | 475.67 | 343.82 |
| | | | | |
Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 39.24 | 29.77 | 28.17 | 28.08 | 20.30 |
Diluted EPS (Rs.) | 39.24 | 23.35 | 28.17 | 28.08 | 20.30 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 39.24 | 29.77 | 28.17 | 28.08 | 20.30 |
Diluted EPS (Rs.) | 39.24 | 23.35 | 28.17 | 28.08 | 20.30 |
| | | | | |
PBITOE Margin (%) | 28.54 | 23.76 | 23.77 | 21.62 | 19.41 |
PBTE Margin (%) | 32.31 | 27.40 | 26.69 | 23.86 | 22.68 |
PBT Margin (%) | 32.48 | 21.61 | 26.23 | 23.14 | 20.43 |
PAT Margin (%) | 23.95 | 15.66 | 19.36 | 19.27 | 14.41 |
PAT After MI And SOA Margin (%) | 23.95 | 15.66 | 19.36 | 19.27 | 14.41 |